National Cancer Institute; Notice of Meeting, 13637-13638 [2017-04917]
Download as PDF
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 82, No. 48 / Tuesday, March 14, 2017 / Notices
respondent) and are low-cost for both
the respondents and the Federal
Government;
• The collections are noncontroversial and do not raise issues of
concern to other Federal agencies;
• Any collection is targeted to the
solicitation of opinions from
respondents who have experience with
the program or may have experience
with the program in the near future;
• Personally identifiable information
(PII) is collected only to the extent
necessary and is not retained;
• Information gathered will be used
only internally for general service
improvement and program management
purposes and is not intended for release
outside of the agency;
• Information gathered will not be
used for the purpose of substantially
informing influential policy decisions;
and
• Information gathered will yield
qualitative information; the collections
will not be designed or expected to
yield statistically reliable results or used
as though the results are generalizable to
the population of study.
Feedback collected under this generic
clearance provides useful information,
but it does not yield data that can be
generalized to the overall population.
This type of generic clearance for
qualitative information will not be used
for quantitative information collections
that are designed to yield reliably
actionable results, such as monitoring
trends over time or documenting
program performance. Such data uses
require more rigorous designs that
address: The target population to which
generalizations will be made, the
sampling frame, the sample design
(including stratification and clustering),
the precision requirements or power
calculations that justify the proposed
sample size, the expected response rate,
methods for assessing potential nonresponse bias, the protocols for data
collection, and any testing procedures
that were or will be undertaken prior to
fielding the study. Depending on the
degree of influence the results are likely
to have, such collections may still be
eligible for submission for other generic
mechanisms that are designed to yield
quantitative results.
As a general matter, information
collections will not result in any new
system of records containing privacy
information and will not ask questions
of a sensitive nature, such as sexual
behavior and attitudes, religious beliefs,
and other matters that are commonly
considered private.
Current Actions: New approval for a
collection of information.
Type of Review: New.
VerDate Sep<11>2014
17:42 Mar 13, 2017
Jkt 241001
Affected Public: Individuals,
households, professionals, public/
private sector.
Estimated Number of Respondents:
3,000,000 over 3 years.
Below we provide projected average
estimates for the next three years:
Average Expected Annual Number of
Activities: 600.
Average Number of Respondents per
Activity: 50.
Annual Responses: 30,000.
Frequency of Response: Once per
request.
Average Minutes per Response: 30.
Burden hours: 500,000.
Request for Comments: Comments
submitted in response to this notice will
be summarized and/or included in the
request for OMB approval. Comments
are invited on: (a) Whether the
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
collection of information; (c) ways to
enhance the quality, utility, and clarity
of the information to be collected; (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology;
and (e) estimates of capital or start-up
costs and costs of operation,
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
information.
All written comments will be
available for public inspection
Regulations.gov.
An agency may not conduct or
sponsor, and a person is not required to
respond to, a collection of information
unless it displays a currently valid
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
13637
Office of Management and Budget
control number.
Darius Taylor,
Information Collection Clearance Officer.
[FR Doc. 2017–04989 Filed 3–13–17; 8:45 am]
BILLING CODE 4150–25–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Cancer Institute Council of
Research Advocates.
The meeting will be held as a webinar
only and is open to the public to join/
dial-in for participation. Individuals
who plan to join/dial-in to the meeting
and need special assistance or other
reasonable accommodations in order to
do so, should notify the Contact Person
listed below in advance of the meeting.
Name of Committee: National Cancer
Institute Council of Research Advocates.
Date: March 30, 2017.
Time: 11:30 a.m. to 1:30 p.m.
Agenda: NCI Acting Director’s Update and
Legislative Update.
Place: National Institutes of Health, 31
Center Drive, Building 31, Room 10A03,
Bethesda, MD 20892.
Webinar Link: https://cbiit.webex.com/
cbiit/j.php?MTID=
m5ec1d366dbaf4c6f4d7a9c6dbe4c48b0.
Meeting number (access code): 736 096
397.
Meeting password: qTgpPZ*6.
(Join by Phone) 1–855–244–8681 Call-in
toll-free number (US/Canada), 1–650–479–
3207 Call-in toll number (US/Canada).
Contact Person: Amy Williams, NCI Office
of Advocacy Relations, National Cancer
Institute, NIH, 31 Center Drive, Building 31,
Room 10A28, Bethesda, MD 20892, 301–594–
3194, williaam@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/ncra/ncra.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
E:\FR\FM\14MRN1.SGM
14MRN1
13638
Federal Register / Vol. 82, No. 48 / Tuesday, March 14, 2017 / Notices
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: March 8, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–04917 Filed 3–13–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Glioblastoma, Multiple Sclerosis,
Alzheimer’s Disease.
Date: April 4, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Samuel C. Edwards, Ph.D.,
Chief, Disorders and Clinical Neuroscience,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 5210, MSC 7846, Bethesda, MD 20892,
(301) 435–1246, edwardss@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–16–
247 Review of Mature Synchrotron Resources
for Structural Biology.
Date: April 6, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Renaissance Washington DC,
Dupont Circle, 1143 New Hampshire Avenue
NW., Washington, DC 20037.
Contact Person: David R. Jollie, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4150,
MSC 7806, Bethesda, MD 20892, (301)–435–
1722, jollieda@csr.nih.gov.
VerDate Sep<11>2014
17:42 Mar 13, 2017
Jkt 241001
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict-Topics in Virology.
Date: April 6, 2017.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Marci Scidmore, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3192,
MSC 7808, Bethesda, MD 20892, 301–435–
1149, marci.scidmore@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict Cell Biology.
Date: April 7, 2017.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: John Burch, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institute of
Health, 6701 Rockledge Drive, Room 3213,
MSC 7808, Bethesda, MD 20892, 301–408–
9519, burchjb@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Infectious
Diseases, Reproductive Health, Asthma and
Pulmonary Conditions, Member Conflicts.
Date: April 7, 2017.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Ellen K. Schwartz, EDD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3144,
MSC 7770, Bethesda, MD 20892, 301–828–
6146, schwarel@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: March 8, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–05004 Filed 3–13–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Environmental
Health Sciences; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Environmental Health Sciences Special
Emphasis Panel; Maintain and Enrich
Resource Infrastructure for Existing
Environmental Epidemiology Cohorts (R24).
Date: April 3–4, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Crystal City, 2799
Jefferson Davis Highway, Arlington, VA
22202.
Contact Person: Linda K. Bass, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research and
Training, Nat. Institute Environmental Health
Sciences, P.O. Box 12233, MD EC–30
Research Triangle Park, NC 27709, (919) 541–
1307, bass@niehs.nih.gov.
Name of Committee: National Institute of
Environmental Health Sciences Special
Emphasis Panel; R13 Conference Grant
Review of Applications.
Date: April 4, 2017.
Time: 11:30 a.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: NIEHS/National Institutes of Health,
Building 4401, East Campus 3003, 79 T.W.
Alexander Drive, Research Triangle Park, NC
27709 (Telephone Conference Call).
Contact Person: Laura A., Thomas,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research and
Training, National Institute of Environmental
Health Sciences, Research Triangle Park, NC
27709, 919–541–2824, laura.thomas@
nih.gov.
Name of Committee: National Institute of
Environmental Health Sciences Special
Emphasis Panel; Revolutionizing Innovative,
Visionary Environmental Health Research
(RIVER).
Date: April 6, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Place Durham-Southpoint,
7840 NC 751 Hwy, Durham, NC 27713.
Contact Person: Leroy Worth, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research and
Training, Nat. Institute of Environmental
Health Sciences, P.O. Box 12233, MD EC–30/
Room 3171, Research Triangle Park, NC
27709, (919) 541–0670, worth@niehs.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.115, Biometry and Risk
E:\FR\FM\14MRN1.SGM
14MRN1
Agencies
[Federal Register Volume 82, Number 48 (Tuesday, March 14, 2017)]
[Notices]
[Pages 13637-13638]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-04917]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
National Cancer Institute Council of Research Advocates.
The meeting will be held as a webinar only and is open to the
public to join/dial-in for participation. Individuals who plan to join/
dial-in to the meeting and need special assistance or other reasonable
accommodations in order to do so, should notify the Contact Person
listed below in advance of the meeting.
Name of Committee: National Cancer Institute Council of Research
Advocates.
Date: March 30, 2017.
Time: 11:30 a.m. to 1:30 p.m.
Agenda: NCI Acting Director's Update and Legislative Update.
Place: National Institutes of Health, 31 Center Drive, Building
31, Room 10A03, Bethesda, MD 20892.
Webinar Link: https://cbiit.webex.com/cbiit/j.php?MTID=m5ec1d366dbaf4c6f4d7a9c6dbe4c48b0.
Meeting number (access code): 736 096 397.
Meeting password: qTgpPZ*6.
(Join by Phone) 1-855-244-8681 Call-in toll-free number (US/
Canada), 1-650-479-3207 Call-in toll number (US/Canada).
Contact Person: Amy Williams, NCI Office of Advocacy Relations,
National Cancer Institute, NIH, 31 Center Drive, Building 31, Room
10A28, Bethesda, MD 20892, 301-594-3194, williaam@mail.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: https://deainfo.nci.nih.gov/advisory/ncra/ncra.htm, where an
agenda and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
[[Page 13638]]
Research; 93.397, Cancer Centers Support; 93.398, Cancer Research
Manpower; 93.399, Cancer Control, National Institutes of Health,
HHS)
Dated: March 8, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-04917 Filed 3-13-17; 8:45 am]
BILLING CODE 4140-01-P